deltatrials
Unknown PHASE4 INTERVENTIONAL 3-arm NCT04357002

Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Abdominal Myomectomy

Evaluating Safety and Efficacy of Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Reducing Intraoperative Blood Loss During Abdominal Myomectomy: a Randomized Controlled Trial

Sponsor: Cairo University

Conditions Myomectomy
Updated 5 times since 2020 Last updated: Apr 20, 2020 Started: Apr 30, 2020 Primary completion: Oct 1, 2020 Completion: Oct 15, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Myomectomy and is currently ongoing. Cairo University leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2020 – ~Jan 2021 · 8 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~May 2022 · 16 months · monthly snapshotNot Yet Recruiting~May 2022 – ~Jul 2024 · 26 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  3. May 2022 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: Not Yet RecruitingUnknown Status

  4. Jan 2021 — May 2022 [monthly]

    Not Yet Recruiting PHASE4

  5. May 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cairo University
Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.